vs
agilon health, inc.(AGL)与Quipt Home Medical Corp.(QIPT)财务数据对比。点击上方公司名可切换其他公司
agilon health, inc.的季度营收约是Quipt Home Medical Corp.的32.0倍($1.6B vs $49.0M)。Quipt Home Medical Corp.净利率更高(-2.1% vs -12.0%,领先9.9%)。Quipt Home Medical Corp.同比增速更快(32.3% vs 3.1%)。Quipt Home Medical Corp.自由现金流更多($6.9M vs $-23.5M)
agilon health是一家美国医疗保健企业,主要与基层医疗服务提供者合作,为联邦医疗保险覆盖的老年群体提供价值导向型医疗解决方案,为医生提供行政支持、临床工具及风险管理框架,在提升诊疗效果的同时降低医疗成本,业务覆盖美国20余个州。
Quipt Home Medical Corp是一家总部位于美国的家用医疗设备服务商,主营呼吸护理、睡眠治疗用品及慢性病管理相关医疗产品,面向慢性病患者群体提供服务,合作方涵盖医疗机构与保险支付机构。
AGL vs QIPT — 直观对比
营收规模更大
AGL
是对方的32.0倍
$49.0M
营收增速更快
QIPT
高出29.2%
3.1%
净利率更高
QIPT
高出9.9%
-12.0%
自由现金流更多
QIPT
多$30.4M
$-23.5M
损益表 — Q4 2025 vs Q1 2026
| 指标 | ||
|---|---|---|
| 营收 | $1.6B | $49.0M |
| 净利润 | $-188.9M | $-1.1M |
| 毛利率 | — | 53.5% |
| 营业利润率 | -12.3% | 2.1% |
| 净利率 | -12.0% | -2.1% |
| 营收同比 | 3.1% | 32.3% |
| 净利润同比 | -78.5% | 2.9% |
| 每股收益(稀释后) | — | $-0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
AGL
QIPT
| Q4 25 | $1.6B | $49.0M | ||
| Q3 25 | $1.4B | $39.8M | ||
| Q2 25 | $1.4B | $35.1M | ||
| Q1 25 | $1.5B | $33.3M | ||
| Q4 24 | $1.5B | $37.1M | ||
| Q3 24 | $1.5B | — | ||
| Q2 24 | $1.5B | — | ||
| Q1 24 | $1.6B | — |
净利润
AGL
QIPT
| Q4 25 | $-188.9M | $-1.1M | ||
| Q3 25 | $-110.2M | $-3.5M | ||
| Q2 25 | $-104.4M | $-3.0M | ||
| Q1 25 | $12.1M | $-3.0M | ||
| Q4 24 | $-105.8M | $-1.1M | ||
| Q3 24 | $-117.6M | — | ||
| Q2 24 | $-30.7M | — | ||
| Q1 24 | $-6.1M | — |
毛利率
AGL
QIPT
| Q4 25 | — | 53.5% | ||
| Q3 25 | — | 48.7% | ||
| Q2 25 | — | 57.6% | ||
| Q1 25 | — | 54.6% | ||
| Q4 24 | — | 52.1% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率
AGL
QIPT
| Q4 25 | -12.3% | 2.1% | ||
| Q3 25 | -9.1% | -3.6% | ||
| Q2 25 | -8.3% | -5.2% | ||
| Q1 25 | -1.4% | -3.0% | ||
| Q4 24 | -7.1% | 1.2% | ||
| Q3 24 | -9.2% | — | ||
| Q2 24 | -2.9% | — | ||
| Q1 24 | -0.4% | — |
净利率
AGL
QIPT
| Q4 25 | -12.0% | -2.1% | ||
| Q3 25 | -7.7% | -8.9% | ||
| Q2 25 | -7.5% | -8.6% | ||
| Q1 25 | 0.8% | -9.1% | ||
| Q4 24 | -6.9% | -2.9% | ||
| Q3 24 | -8.1% | — | ||
| Q2 24 | -2.1% | — | ||
| Q1 24 | -0.4% | — |
每股收益(稀释后)
AGL
QIPT
| Q4 25 | — | $-0.02 | ||
| Q3 25 | — | $-0.07 | ||
| Q2 25 | — | $-0.07 | ||
| Q1 25 | — | $-0.07 | ||
| Q4 24 | — | $-0.03 | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $173.7M | $10.5M |
| 总债务越低越好 | $35.0M | $84.0M |
| 股东权益账面价值 | $126.7M | $113.0M |
| 总资产 | $1.3B | $280.7M |
| 负债/权益比越低杠杆越低 | 0.28× | 0.74× |
8季度趋势,按日历期对齐
现金及短期投资
AGL
QIPT
| Q4 25 | $173.7M | $10.5M | ||
| Q3 25 | $171.7M | $12.9M | ||
| Q2 25 | $171.4M | $11.3M | ||
| Q1 25 | $136.9M | $17.1M | ||
| Q4 24 | $188.2M | $15.5M | ||
| Q3 24 | $148.2M | — | ||
| Q2 24 | $109.5M | — | ||
| Q1 24 | $111.7M | — |
总债务
AGL
QIPT
| Q4 25 | $35.0M | $84.0M | ||
| Q3 25 | — | $87.6M | ||
| Q2 25 | — | $66.0M | ||
| Q1 25 | — | $71.5M | ||
| Q4 24 | — | $70.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益
AGL
QIPT
| Q4 25 | $126.7M | $113.0M | ||
| Q3 25 | $306.1M | $112.1M | ||
| Q2 25 | $408.9M | $102.5M | ||
| Q1 25 | $500.3M | $103.6M | ||
| Q4 24 | $471.0M | $106.3M | ||
| Q3 24 | $574.9M | — | ||
| Q2 24 | $676.6M | — | ||
| Q1 24 | $689.3M | — |
总资产
AGL
QIPT
| Q4 25 | $1.3B | $280.7M | ||
| Q3 25 | $1.6B | $283.3M | ||
| Q2 25 | $1.7B | $236.1M | ||
| Q1 25 | $1.9B | $244.6M | ||
| Q4 24 | $1.7B | $242.8M | ||
| Q3 24 | $2.1B | — | ||
| Q2 24 | $2.2B | — | ||
| Q1 24 | $2.3B | — |
负债/权益比
AGL
QIPT
| Q4 25 | 0.28× | 0.74× | ||
| Q3 25 | — | 0.78× | ||
| Q2 25 | — | 0.64× | ||
| Q1 25 | — | 0.69× | ||
| Q4 24 | — | 0.66× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-20.5M | $8.9M |
| 自由现金流经营现金流 - 资本支出 | $-23.5M | $6.9M |
| 自由现金流率自由现金流/营收 | -1.5% | 14.0% |
| 资本支出强度资本支出/营收 | 0.2% | 4.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-119.0M | $26.6M |
8季度趋势,按日历期对齐
经营现金流
AGL
QIPT
| Q4 25 | $-20.5M | $8.9M | ||
| Q3 25 | $-18.2M | $9.8M | ||
| Q2 25 | $-35.1M | $9.7M | ||
| Q1 25 | $-32.0M | $8.9M | ||
| Q4 24 | $16.4M | $9.3M | ||
| Q3 24 | $-7.7M | — | ||
| Q2 24 | $-18.7M | — | ||
| Q1 24 | $-47.8M | — |
自由现金流
AGL
QIPT
| Q4 25 | $-23.5M | $6.9M | ||
| Q3 25 | $-21.3M | $8.0M | ||
| Q2 25 | $-38.3M | $4.4M | ||
| Q1 25 | $-35.8M | $7.3M | ||
| Q4 24 | $13.2M | $5.6M | ||
| Q3 24 | $-11.2M | — | ||
| Q2 24 | $-22.0M | — | ||
| Q1 24 | $-50.9M | — |
自由现金流率
AGL
QIPT
| Q4 25 | -1.5% | 14.0% | ||
| Q3 25 | -1.5% | 20.0% | ||
| Q2 25 | -2.7% | 12.6% | ||
| Q1 25 | -2.3% | 22.0% | ||
| Q4 24 | 0.9% | 15.2% | ||
| Q3 24 | -0.8% | — | ||
| Q2 24 | -1.5% | — | ||
| Q1 24 | -3.2% | — |
资本支出强度
AGL
QIPT
| Q4 25 | 0.2% | 4.2% | ||
| Q3 25 | 0.2% | 4.6% | ||
| Q2 25 | 0.2% | 14.9% | ||
| Q1 25 | 0.3% | 4.8% | ||
| Q4 24 | 0.2% | 9.9% | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 0.2% | — |
现金转化率
AGL
QIPT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -2.64× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AGL
| Medical Services | $1.6B | 100% |
| Other Operating | $2.5M | 0% |
QIPT
暂无分部数据